Allo-HCT refined ELN 2022 risk classification: validation of the Adverse-Plus risk group in AML patients undergoing allogeneic hematopoietic cell transplantation within the Spanish Group for Hematopoietic Cell Transplantation (GETH-TC)
Allo-HCT 改进 ELN 2022 风险分类:在西班牙造血细胞移植组 (GETH-TC) 中验证接受异基因造血细胞移植的 AML 患者的不良附加风险组
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01223-x
Jiménez-Vicente, Carlos; Esteve, Jordi; Baile-González, Mónica; Pérez-López, Estefanía; Martin Calvo, Carmen; Aparicio, Clara; Oiartzabal Ormategi, Itziar; Esquirol, Albert; Peña-Muñoz, Felipe; Fernández-Luis, Sara; Heras Fernando, Inmaculada; González-Rodríguez, Ana Pilar; López-García, Alberto; López-Lorenzo, Jose Luis; Torrado, Tamara; Sáez Marín, Adolfo Jesús; Acosta Fleytas, Cynthia; García, Lucía; Villar, Sara; Filaferro, Silvia; Balsalobre, Pascual; Pascual Cascón, María Jesús; Salas, María Queralt